Literature DB >> 32986373

Incidence of and Risk Factors for Tuberculosis among Cancer Patients in Endemic Area: A Regional Cohort Study.

Sirinya Nanthanangkul1,2, Supannee Promthet2, Krittika Suwanrungruang2,3, Chalongpon Santong3, Patravoot Vatanasapt2,3,4.   

Abstract

BACKGROUND AND
OBJECTIVE: Cancer is a known risk factor for developing active tuberculosis (TB) disease. The incidence of and risk factors for TB are not known among cancer patients in Thailand. This study aimed to investigate risk factors for TB among cancer patients in an area with endemic TB infections.
METHODS: We used the Khon Kaen population-based cancer registry and two TB databases to conduct a retrospective cohort study of cancer patients. From 2001 to 2015, we identified 40,948 eligible cancer patients. Following until 2017, we identified cases of TB diagnosed after cancer diagnosis and analyzed primary cancer site, staging, treatment, and demographic factors. Adjusted incidence rate ratios (adj. IRR) were computed to identify risk factors among a sub-set of cancer types (n = 9,733) using Poisson regression.
RESULTS: Among all cancer patients, 472 cases of TB were diagnosed following cancer diagnosis (cumulative incidence = 1.15%, incidence rate = 421.86 cases per 100,000 patients per year). Among the sub-set of cancer types, 206 cases of TB were found (cumulative incidence = 2.11%, incidence rate = 848.26 cases per 100,000 patients per year). Risk factors for TB among cancer patients were sex (p < 0.001) (male adj. IRR  = 1.87, 95% CI: 1.36-2.59), age (p < 0.001) (age >70 adj. IRR  = 2.36, 95% CI: 1.56-3.55, compared to age ≤50) and cancer site (p < 0.001). Compared to thyroid cancer, TB infection was more associated with lung cancer without histopathological confirmation (adj. IRR  = 6.22, 95% CI: 2.57-15.04). Cancer stage and treatment did not show statistically significant trends.
CONCLUSION: Old age, male sex, and certain cancer types were independent risk factors for TB in cancer patients. Targeted latent TB screening may be appropriate among high risk groups.

Entities:  

Keywords:  Epidemiology; Malignancy; Screening; Tuberculosis; latent infection

Mesh:

Year:  2020        PMID: 32986373      PMCID: PMC7779434          DOI: 10.31557/APJCP.2020.21.9.2715

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  24 in total

Review 1.  Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

Review 2.  The aging of the immune system.

Authors:  Daniela Weiskopf; Birgit Weinberger; Beatrix Grubeck-Loebenstein
Journal:  Transpl Int       Date:  2009-07-16       Impact factor: 3.782

3.  Risk Factors for TB in Patients With Early Gastric Cancer: Is Gastrectomy a Significant Risk Factor for TB?

Authors:  Il Ju Choi; Young-Woo Kim; Hee Seok Lee; Keun Won Ryu; Hong Man Yoon; Bang Wool Eom; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Byung-Ho Nam
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

Review 4.  The twilight of immunity: emerging concepts in aging of the immune system.

Authors:  Janko Nikolich-Žugich
Journal:  Nat Immunol       Date:  2017-12-14       Impact factor: 25.606

5.  Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis.

Authors:  Claudia C Dobler; Kelvin Cheung; John Nguyen; Andrew Martin
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

Review 6.  Sexual inequality in tuberculosis.

Authors:  Olivier Neyrolles; Lluis Quintana-Murci
Journal:  PLoS Med       Date:  2009-12-22       Impact factor: 11.069

Review 7.  Epidemiology of active tuberculosis in lung cancer patients: a systematic review.

Authors:  Antonis Christopoulos; Muhammad W Saif; Evangelos G Sarris; Kostas N Syrigos
Journal:  Clin Respir J       Date:  2014-03-05       Impact factor: 2.570

8.  The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study.

Authors:  Chezi Ganzel; Barbara Silverman; Daniel Chemtob; Assaf Ben Shoham; Yonit Wiener-Well
Journal:  Leuk Lymphoma       Date:  2018-09-06

Review 9.  Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review.

Authors:  Hui-Ying Liang; Xue-Lian Li; Xiao-Song Yu; Peng Guan; Zhi-Hua Yin; Qin-Cheng He; Bao-Sen Zhou
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

10.  An Unusual Triad of Hemophagocytic Syndrome, Lymphoma and Tuberculosis in a Non-HIV Patient.

Authors:  Hafiz Rizwan Talib Hashmi; Rashmi Mishra; Masooma Niazi; Sindhaghatta Venkatram; Gilda Diaz-Fuentes
Journal:  Am J Case Rep       Date:  2017-07-03
View more
  2 in total

1.  Burden, risk factors, and management of neutropenic fever among solid cancer patients in Ethiopia.

Authors:  Samuel Agegnew Wondm; Ephrem Mebratu Dagnew; Sumeya Tadesse Abegaz; Mekdes Kiflu; Bekalu Kebede
Journal:  SAGE Open Med       Date:  2022-05-19

2.  Survival of Cancer Patients with Co-Morbid Tuberculosis in Thailand.

Authors:  Pallop Siewchaisakul; Sirinya Nanthanangkul; Chalongpon Santong; Krittika Suwanrungruang; Patravoot Vatanasapt
Journal:  Asian Pac J Cancer Prev       Date:  2021-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.